Preferred Vascular Group, LLC

Based in the US, Preferred Vascular Group, LLC specializes in vascular treatment solutions, providing advanced, minimally invasive procedures such as Genicular Artery Embolization and Uterine Fibroid Embolization for various vascular-related health issues. Preferred Vascular Group, LLC, founded in 2005, focuses on vascular treatment solutions. The firm is headquartered in Naples, US, founded by Don Holton and has engaged in one significant deal as of March 2, 2026, when it was acquired by Surgery Partners, Inc. , allowing for enhanced presence in the vascular market.

Preferred Vascular Group specializes in providing a comprehensive range of vascular treatment solutions, including Genicular Artery Embolization (GAE) for knee pain relief, Uterine Fibroid Embolization (UFE), and management of dialysis access. These minimally invasive procedures are designed to alleviate conditions such as osteoarthritis, uterine fibroids, and provide reliable access for dialysis patients. The GAE procedure specifically targets and blocks blood vessels that contribute to knee pain and inflammation, while UFE addresses symptoms related to uterine fibroids by obstructing their blood supply. Preferred Vascular Group serves a diverse client base that encompasses patients requiring vascular intervention, nephrologists, and healthcare providers, primarily in the greater Atlanta area and Northeast Ohio.

The firm operates through eight locations, ensuring its services are accessible to patients across these regions, with an emphasis on patient-centered care and community involvement. Preferred Vascular Group generates revenue through direct patient services for vascular treatments, including GAE and UFE, as well as dialysis access management. Revenue transactions typically occur on a fee-for-service basis, where patients or their insurers directly pay for the procedures rendered. Preferred Vascular Group has established relationships with healthcare providers and nephrologists who refer patients for these specialized services, creating a consistent flow of business.

The firm may offer various pricing structures based on the complexity and type of procedure performed, ensuring patients receive tailored treatment options. Given its focus on outpatient care, the company provides same-day appointments, facilitating a streamlined process for both patients and referring healthcare practitioners. In March 2026, Surgery Partners, Inc. , a portfolio company of Bain Capital, acquired Preferred Vascular Group, LLC.

The rationale for this acquisition is to enhance Surgery Partners, Inc. 's presence in the vascular market. Future growth strategies may focus on the development of new vascular treatment products and expanding operations into additional geographic regions, although specific details about new product launches and targeted markets have not been disclosed.